uncy: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	39,862	13,530
Net increase in cash and cash equivalents	16,553	-3,815
Cash and cash equivalents at beginning of period	26,142	-
Cash and cash equivalents at end of period	42,695	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	39,862	13,530
Net increase in cash and cash equivalents	16,553	-3,815
Cash and cash equivalents at beginning of period	26,142	-
Cash and cash equivalents at end of period	42,695	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Unicycive Therapeutics, Inc. (UNCY)